BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Indraprastha Medical Corporation Ltd Industry :  Healthcare
BSE Code
532150
ISIN Demat
INE681B01017
Book Value (Rs)
71.8164563
NSE Symbol
INDRAMEDCO
Divident Yield %
0.73
Market Cap
(Rs In Cr.)
5,681
P/E (TTM)
32.51
EPS (TTM)
19.06
Face Value
(Rs)
10
Back
Indraprastha Medical Corporation standalone net profit rises 16.65% in the September 2025 quarter
03-Nov-25   Hrs IST

Net profit of Indraprastha Medical Corporation rose 16.65% to Rs 49.46 crore in the quarter ended September 2025 as against Rs 42.40 crore during the previous quarter ended September 2024. Sales rose 8.92% to Rs 381.03 crore in the quarter ended September 2025 as against Rs 349.82 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales381.03349.82 9
OPM %18.7218.19 -
PBDT77.1768.10 13
PBT66.3156.93 16
NP49.4642.40 17

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)